| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal hemostasis in children with vascular anomalies, part I: Thrombocytopenias among different vascular anomalies
|
Tole, Soumitra
|
|
|
196 |
C |
p. 626-634
|
artikel
|
| 2 |
A comparison of methods for prediction of pharmacokinetics when switching to extended half-life products in hemophilia A patients
|
Yu, Jacky K.
|
|
|
196 |
C |
p. 550-558
|
artikel
|
| 3 |
Acquired platelet function disorders
|
Brennan, Yvonne
|
|
|
196 |
C |
p. 561-568
|
artikel
|
| 4 |
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19
|
Naymagon, Leonard
|
|
|
196 |
C |
p. 99-105
|
artikel
|
| 5 |
AMPK inhibition protects against arterial thrombosis while sparing hemostasis through differential modulation of platelet responses
|
Kulkarni, Paresh P.
|
|
|
196 |
C |
p. 175-185
|
artikel
|
| 6 |
A new hybrid immunocapture bioassay with improved reproducibility to measure tissue factor-dependent procoagulant activity of microvesicles from body fluids
|
Franco, Corentin
|
|
|
196 |
C |
p. 414-424
|
artikel
|
| 7 |
Anticoagulation and bleeding risk in patients with COVID-19
|
Musoke, Nancy
|
|
|
196 |
C |
p. 227-230
|
artikel
|
| 8 |
Anticoagulation control with the point-of-care INR: A retrospective pre-/post-analysis
|
Riva, Nicoletta
|
|
|
196 |
C |
p. 21-24
|
artikel
|
| 9 |
Anticoagulation in COVID-19: Randomized trials should set the balance between excitement and evidence
|
Bikdeli, Behnood
|
|
|
196 |
C |
p. 638-640
|
artikel
|
| 10 |
Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit
|
Vlot, E.A.
|
|
|
196 |
C |
p. 1-3
|
artikel
|
| 11 |
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
|
Trunfio, Mattia
|
|
|
196 |
C |
p. 432-434
|
artikel
|
| 12 |
Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system
|
Jakowenko, Nicholas
|
|
|
196 |
C |
p. 276-282
|
artikel
|
| 13 |
Aspirin related platelet reactivity as a determinant of ten year survival in high risk non-ST segment elevation myocardial infarction (NSTEMI) patients
|
Khan, Nazish
|
|
|
196 |
C |
p. 523-525
|
artikel
|
| 14 |
Association between Covid-19 and Pulmonary Embolism (AC-19-PE study)
|
Miró, Òscar
|
|
|
196 |
C |
p. 322-324
|
artikel
|
| 15 |
Association of fractalkine with functional severity of heart failure and impact on clopidogrel efficacy in patients with ischemic heart disease
|
Marcano, Ana Lucrecia
|
|
|
196 |
C |
p. 215-221
|
artikel
|
| 16 |
Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity
|
Torres-Machorro, Adriana
|
|
|
196 |
C |
p. 268-271
|
artikel
|
| 17 |
Bacterial outer membrane vesicles induce disseminated intravascular coagulation through the caspase-11-gasdermin D pathway
|
Peng, Yue
|
|
|
196 |
C |
p. 159-166
|
artikel
|
| 18 |
Biomarker-enhanced VTE risk stratification in ambulatory patients with cancer
|
Shaw, Joseph R.
|
|
|
196 |
C |
p. 437-443
|
artikel
|
| 19 |
Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients
|
Dujardin, Romein W.G.
|
|
|
196 |
C |
p. 308-312
|
artikel
|
| 20 |
Can anticoagulants improve the survival rate for patients with idiopathic pulmonary arterial hypertension? A systematic review and meta-analysis
|
Wang, Peijie
|
|
|
196 |
C |
p. 251-256
|
artikel
|
| 21 |
Circulating levels of the terminal complement complex are associated with hypercoagulability in patients with stable coronary artery disease
|
Kluge, Karsten E.
|
|
|
196 |
C |
p. 106-108
|
artikel
|
| 22 |
Clinical and laboratory diagnosis of rare coagulation disorders (RCDs)
|
Menegatti, Marzia
|
|
|
196 |
C |
p. 603-608
|
artikel
|
| 23 |
Clotting abnormalities in critically ill COVID-19 patients are inconsistent with overt disseminated intravascular coagulation
|
Paparella, Domenico
|
|
|
196 |
C |
p. 272-275
|
artikel
|
| 24 |
Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency
|
Pizzi, Roberto
|
|
|
196 |
C |
p. 209-212
|
artikel
|
| 25 |
Comparison of the Wells score and the revised Geneva score as a tool to predict pulmonary embolism in outpatients over age 65
|
Coelho, Julien
|
|
|
196 |
C |
p. 120-126
|
artikel
|
| 26 |
Congenital fibrinogen disorder with a compound heterozygote possessing two novel FGB mutations, one qualitative and the other quantitative
|
Yoda, Masahiro
|
|
|
196 |
C |
p. 152-158
|
artikel
|
| 27 |
Corrigendum to “Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism” [Thromb. Res. 193 (2020) 160–165]
|
Trujillo-Santos, Javier
|
|
|
196 |
C |
p. 641
|
artikel
|
| 28 |
Cost-effectiveness of edoxaban vs low-molecular-weight heparin and warfarin for cancer-associated thrombosis in Brazil
|
Lopes, Danilo G.
|
|
|
196 |
C |
p. 4-10
|
artikel
|
| 29 |
COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?
|
Del Turco, Serena
|
|
|
196 |
C |
p. 143-151
|
artikel
|
| 30 |
COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy
|
Daughety, Molly M.
|
|
|
196 |
C |
p. 483-485
|
artikel
|
| 31 |
COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic
|
Parks, Anna L.
|
|
|
196 |
C |
p. 355-358
|
artikel
|
| 32 |
COVID-19 versus HIT hypercoagulability
|
Warkentin, Theodore E.
|
|
|
196 |
C |
p. 38-51
|
artikel
|
| 33 |
D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19
|
Choi, Justin J.
|
|
|
196 |
C |
p. 318-321
|
artikel
|
| 34 |
D-dimer measurement in COVID-19: Silver bullet or clinical distraction?
|
Lippi, Giuseppe
|
|
|
196 |
C |
p. 635-637
|
artikel
|
| 35 |
Demystifying pulmonary vascular complications in severe coronavirus disease-19 pneumonia (COVID-19) in the light of clinico-radiologic-pathologic correlation
|
Parry, Arshed Hussain
|
|
|
196 |
C |
p. 559-560
|
artikel
|
| 36 |
Determining the maximal storage time of centrifuged citrated samples for performing add-on routine coagulation tests
|
Denessen, E.J.S.
|
|
|
196 |
C |
p. 54-62
|
artikel
|
| 37 |
Does high on-treatment platelet aggregability reflect poor individual response to clopidogrel?
|
Nooney, Vivek B.
|
|
|
196 |
C |
p. 510-515
|
artikel
|
| 38 |
Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study
|
Chopard, Romain
|
|
|
196 |
C |
p. 476-482
|
artikel
|
| 39 |
Editorial Board
|
|
|
|
196 |
C |
p. IFC
|
artikel
|
| 40 |
Efficacy and safety of non-vitamin K anticoagulants and warfarin in patients with atrial fibrillation and heart failure: A network meta-analysis
|
Jin, Hao
|
|
|
196 |
C |
p. 109-119
|
artikel
|
| 41 |
ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months
|
Agnelli, Giancarlo
|
|
|
196 |
C |
p. 297-304
|
artikel
|
| 42 |
Extended half-life recombinant products in haemophilia clinical practice – Expectations, opportunities and challenges
|
Chowdary, Pratima
|
|
|
196 |
C |
p. 609-617
|
artikel
|
| 43 |
Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia
|
Beenen, L.F.M.
|
|
|
196 |
C |
p. 135-137
|
artikel
|
| 44 |
Extracellular histones promote fibrinolysis by single-chain urokinase-type plasminogen activator in a factor seven activating protease-dependent way
|
Semeraro, Fabrizio
|
|
|
196 |
C |
p. 193-199
|
artikel
|
| 45 |
Fibrinogen BOE II: Intracerebral hemorrhage associated with a novel compound mutation in a Chinese family with dysfibrinogenemia
|
Wang, Xiaoyu
|
|
|
196 |
C |
p. 63-66
|
artikel
|
| 46 |
Genetic and molecular evidence for complement dysregulation in patients with HELLP syndrome
|
Bazzan, Mario
|
|
|
196 |
C |
p. 167-174
|
artikel
|
| 47 |
Hemorrhagic, thrombotic and obstetric complications of congenital dysfibrinogenemia in a previously asymptomatic woman
|
Peterson, Wynn
|
|
|
196 |
C |
p. 127-129
|
artikel
|
| 48 |
Heparin-induced thrombocytopenia and thrombosis in a patient with Covid-19
|
Huang, Ching-Tai
|
|
|
196 |
C |
p. 11-14
|
artikel
|
| 49 |
Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients
|
Hoechter, D.J.
|
|
|
196 |
C |
p. 186-192
|
artikel
|
| 50 |
High levels of endothelial and platelet microvesicles in patients with type 1 diabetes irrespective of microvascular complications
|
Bergen, Karin
|
|
|
196 |
C |
p. 78-86
|
artikel
|
| 51 |
High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score
|
Castellón Rubio, Victoria E.
|
|
|
196 |
C |
p. 349-354
|
artikel
|
| 52 |
How I treat von Willebrand disease
|
Castaman, Giancarlo
|
|
|
196 |
C |
p. 618-625
|
artikel
|
| 53 |
How we make an accurate diagnosis of von Willebrand disease
|
Baronciani, Luciano
|
|
|
196 |
C |
p. 579-589
|
artikel
|
| 54 |
Identification of the antithrombotic protein S as a potential target of the SARS-CoV-2 papain-like protease
|
Ruzicka, Jan A.
|
|
|
196 |
C |
p. 257-259
|
artikel
|
| 55 |
Impact of atrial fibrillation/flutter on the in-hospital mortality of surgical patients – Results from the German nationwide cohort
|
Keller, Karsten
|
|
|
196 |
C |
p. 526-535
|
artikel
|
| 56 |
Impact of the rs73598374 polymorphism of the adenosine deaminase gene on platelet reactivity and long-term outcomes among patients with acute coronary syndrome treated with ticagrelor
|
Verdoia, Monica
|
|
|
196 |
C |
p. 231-237
|
artikel
|
| 57 |
Incidence of thrombotic outcomes for patients hospitalized and discharged after COVID-19 infection
|
Bourguignon, Alex
|
|
|
196 |
C |
p. 491-493
|
artikel
|
| 58 |
Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis
|
Kunutsor, Setor K.
|
|
|
196 |
C |
p. 27-30
|
artikel
|
| 59 |
Increased D-dimer predicts the risk of cancer-associated recurrent venous thromboembolism and venous thromboembolism: A systematic review and meta-analysis
|
Yang, Meng
|
|
|
196 |
C |
p. 410-413
|
artikel
|
| 60 |
Increased oxidative stress may be a risk factor for thromboembolic complications in patients with antiphospholipid syndrome
|
Nojima, Junzo
|
|
|
196 |
C |
p. 52-53
|
artikel
|
| 61 |
In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist
|
Wang, Lan
|
|
|
196 |
C |
p. 541-542
|
artikel
|
| 62 |
Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia
|
Hsu, Andrew
|
|
|
196 |
C |
p. 375-378
|
artikel
|
| 63 |
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
|
Bikdeli, Behnood
|
|
|
196 |
C |
p. 382-394
|
artikel
|
| 64 |
Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function
|
Liu, Jingxuan
|
|
|
196 |
C |
p. 200-205
|
artikel
|
| 65 |
Lemierre syndrome: Current evidence and rationale of the Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry
|
Valerio, Luca
|
|
|
196 |
C |
p. 494-499
|
artikel
|
| 66 |
Long-term anticoagulant treatment in patients with inferior vena cava agenesis and deep vein thrombosis
|
Oblitas, Crhistian Mario
|
|
|
196 |
C |
p. 305-307
|
artikel
|
| 67 |
Long-term bleeding risk vs. mortality risk in acute coronary syndrome patients according to the 2019 ARC-HBR definition
|
Cordero, Alberto
|
|
|
196 |
C |
p. 516-518
|
artikel
|
| 68 |
Managing suspected venous thromboembolism when a pandemic limits diagnostic testing
|
Schaefer, Jordan K.
|
|
|
196 |
C |
p. 213-214
|
artikel
|
| 69 |
Meta-analysis fever in the wake of CARAVAGGIO
|
Haykal, Tarek
|
|
|
196 |
C |
p. 141-142
|
artikel
|
| 70 |
More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism
|
van Dam, L.F.
|
|
|
196 |
C |
p. 435-436
|
artikel
|
| 71 |
More precise dosing of acenocoumarol for better control in patients aged above 80 years, a randomised controlled pilot study
|
Piersma-Wichers, M.
|
|
|
196 |
C |
p. 536-538
|
artikel
|
| 72 |
Outcome of intracranial bleeding managed with prothrombin complex concentrate in patients on direct factor Xa inhibitors or vitamin K antagonists
|
Bavalia, Roisin
|
|
|
196 |
C |
p. 404-409
|
artikel
|
| 73 |
Perspectives of patients and health professionals on important factors influencing rehabilitation following acute pulmonary embolism: A multi-method study
|
Rolving, Nanna
|
|
|
196 |
C |
p. 283-290
|
artikel
|
| 74 |
Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia
|
Jarvis, Kirsten Brunsvig
|
|
|
196 |
C |
p. 15-20
|
artikel
|
| 75 |
Postprandial factor VII activation does not increase plasma concentrations of prothrombin fragment 1 + 2 in patients with morbid obesity
|
Landgrebe, Line Espenhain
|
|
|
196 |
C |
p. 260-267
|
artikel
|
| 76 |
Preoperative and intraoperative predictors of deep venous thrombosis in adult patients undergoing craniotomy for brain tumors: A Chinese single-center, retrospective study
|
Shi, Shuhai
|
|
|
196 |
C |
p. 245-250
|
artikel
|
| 77 |
Proteomics reveals region-specific hemostatic alterations in response to mechanical ventilation in a preterm lamb model of lung injury
|
Schmid, Christine
|
|
|
196 |
C |
p. 466-475
|
artikel
|
| 78 |
Real-life evaluation of an automated immunoassay for diagnosis of heparin-induced thrombocytopenia
|
Althaus, Karina
|
|
|
196 |
C |
p. 400-403
|
artikel
|
| 79 |
Red blood cell supernatant increases activation and agonist-induced reactivity of blood platelets
|
Czubak-Prowizor, Kamila
|
|
|
196 |
C |
p. 543-549
|
artikel
|
| 80 |
Right ventricular dilation: The additive effect of mechanical ventilation on pulmonary embolism in Covid-19 patients
|
Tsolaki, Vasiliki
|
|
|
196 |
C |
p. 25-26
|
artikel
|
| 81 |
Risk of post-thrombotic syndrome after deep vein thrombosis treated with rivaroxaban versus vitamin-K antagonists: A systematic review and meta-analysis
|
Li, Ruihao
|
|
|
196 |
C |
p. 340-348
|
artikel
|
| 82 |
Role of upfront CT pulmonary angiography at admission in COVID-19 patients
|
Jalaber, Carole
|
|
|
196 |
C |
p. 138-140
|
artikel
|
| 83 |
Rotational thromboelastometry to assess hypercoagulability in COVID-19 patients
|
van Veenendaal, Nadine
|
|
|
196 |
C |
p. 379-381
|
artikel
|
| 84 |
Sample stability for routine coagulation testing
|
Favaloro, Emmanuel J.
|
|
|
196 |
C |
p. 130-134
|
artikel
|
| 85 |
Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants (DOACs) in patients with major congenital thrombophilia
|
Serrao, Alessandra
|
|
|
196 |
C |
p. 539-540
|
artikel
|
| 86 |
Serial block-face scanning electron microscopy: A provocative technique to define 3-dimensional ultrastructure of microvascular thrombosis
|
Courson, Justin A.
|
|
|
196 |
C |
p. 519-522
|
artikel
|
| 87 |
Sex-related characteristics of cerebral vein thrombosis: A secondary analysis of a multicenter international cohort study
|
Porceddu, Enrica
|
|
|
196 |
C |
p. 371-374
|
artikel
|
| 88 |
Spontaneous heparin induced thrombocytopenia (HIT) following curettage and bone graft of femur in a patient with monostotic fibrous dysplasia
|
Swarup, Sriman
|
|
|
196 |
C |
p. 75-77
|
artikel
|
| 89 |
Sub-segmental pulmonary emboli as a marker of CT-pulmonary angiogram overuse in a single-center retrospective cohort study: A dimer a dozen?
|
Gerstein, Lindsey
|
|
|
196 |
C |
p. 463-465
|
artikel
|
| 90 |
Systemic thromboemboli in patients with Covid-19 may result from paradoxical embolization
|
Rajendram, Rajkumar
|
|
|
196 |
C |
p. 206-208
|
artikel
|
| 91 |
Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolism
|
Delate, Thomas
|
|
|
196 |
C |
p. 367-370
|
artikel
|
| 92 |
The domino effect triggered by the tethered ligand of the protease activated receptors
|
Han, Xu
|
|
|
196 |
C |
p. 87-98
|
artikel
|
| 93 |
The hazard of fondaparinux in non-critically ill patients with COVID-19: Retrospective controlled study versus enoxaparin
|
Prandoni, Paolo
|
|
|
196 |
C |
p. 395-397
|
artikel
|
| 94 |
The incidence of thrombotic events with idarucizumab and andexanet alfa: A systematic review and meta-analysis
|
Rodrigues, André Oliveira
|
|
|
196 |
C |
p. 291-296
|
artikel
|
| 95 |
The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison
|
Brüggemann, Renée A.G.
|
|
|
196 |
C |
p. 486-490
|
artikel
|
| 96 |
Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
|
Lemos, Anna Cristina Bertoldi
|
|
|
196 |
C |
p. 359-366
|
artikel
|
| 97 |
The risk factors for perioperative venous thromboembolism in patients with gynecological malignancies: A meta-analysis
|
Ma, Se-Ge
|
|
|
196 |
C |
p. 325-334
|
artikel
|
| 98 |
The use of prophylaxis in the treatment of rare bleeding disorders
|
Shapiro, Amy
|
|
|
196 |
C |
p. 590-602
|
artikel
|
| 99 |
Thrombin generation in subjects with lupus anticoagulant without prior thrombosis or gestational morbidities
|
Velasco-Rodríguez, Diego
|
|
|
196 |
C |
p. 425-431
|
artikel
|
| 100 |
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism
|
Hannevik, Trine-Lise
|
|
|
196 |
C |
p. 238-244
|
artikel
|
| 101 |
Uninterrupted direct oral anticoagulant treatment during acute illness: Impact on clinical outcomes
|
Gueta, Itai
|
|
|
196 |
C |
p. 457-462
|
artikel
|
| 102 |
Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units
|
Doyle, Andrew J.
|
|
|
196 |
C |
p. 454-456
|
artikel
|
| 103 |
Updated meta-analysis on the efficacy of genotype-guided antiplatelet therapy versus standard therapy for patients undergoing PCI
|
Sahashi, Yuki
|
|
|
196 |
C |
p. 398-399
|
artikel
|
| 104 |
Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
|
Zermatten, Maxime G.
|
|
|
196 |
C |
p. 222-226
|
artikel
|
| 105 |
Validation of the PLASMIC score for predicting ADAMTS13 activity <10% in patients with suspected thrombotic thrombocytopenic purpura in Alberta, Canada
|
Wynick, Chris
|
|
|
196 |
C |
p. 335-339
|
artikel
|
| 106 |
Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review
|
Solinas, Cinzia
|
|
|
196 |
C |
p. 444-453
|
artikel
|
| 107 |
Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action
|
Pavoni, Vittorio
|
|
|
196 |
C |
p. 313-317
|
artikel
|
| 108 |
Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis
|
Porfidia, Angelo
|
|
|
196 |
C |
p. 67-74
|
artikel
|
| 109 |
Von Willebrand Factor and ADAMTS13 and long-term outcomes in patients undergoing percutaneous coronary intervention
|
Tscharre, Maximilian
|
|
|
196 |
C |
p. 31-37
|
artikel
|
| 110 |
Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies
|
Han, Xiaorong
|
|
|
196 |
C |
p. 500-509
|
artikel
|
| 111 |
Women with inherited bleeding disorders – Challenges and strategies for improved care
|
Presky, Keren O.
|
|
|
196 |
C |
p. 569-578
|
artikel
|
Tijdschrift beschrijving